Breaks Categories: News

TuesdayMay 07, 2024 11:43 am

NetworkNewsBreaks – Lucid Group Inc. (NASDAQ: LCID) Releases Q1 2024 Financial Report

Lucid Group (NASDAQ: LCID), a company setting new standards for the luxury electric experience with the Lucid Air, America's most awarded new luxury vehicle, is reporting its first quarter 2024 financial results, for the period ended March 31, 2024. Highlights of the report show that the company produced 1,728 vehicles in first quarter, and is on track for annual production of approximately 9,000 vehicles; delivered 1,967 vehicles in Q1, up 39.9% compared to Q1 2023; reached Q1 revenue of $172.7 million; raised $1 billion via private placement to an affiliate of the Public Investment Fund (“PIF”); and has approximately $5.03 billion of total liquidity. “I…

Continue Reading

MondayMay 06, 2024 3:31 pm

NetworkNewsBreaks – Cemtrex Inc. (NASDAQ: CETX) Closes on Upsized Underwritten Public Offering Worth $10M

Cemtrex (NASDAQ: CETX), an advanced-security technology and industrial services company, has closed on a firm-commitment underwritten public offering. According to the announcement, the company will receive an estimated $10 million in gross proceeds from the offering, before standard deductions and expenses. Upsized from an original $9 million commitment, the base offering consisted of 11,764,705 common units or prefunded units; the purchase price of each common unit was $0.85, and the purchase price of each prefunded unit was $0.849. Cemtrex anticipates using the net proceeds from the offering for operations as well as to increase marketing efforts and invest in existing…

Continue Reading

MondayMay 06, 2024 3:20 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Nasdaq Delisting Notification and Appeal, ADS Ratio Change

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company today announced that it has received a staff determination letter on April 30, 2024, from the Listing Qualifications Department of the Nasdaq Stock Market LLC. In the letter, Nasdaq notified the company that, due to its non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), the company's American Depositary Shares (“ADSs”) would be scheduled for delisting from the Nasdaq Capital Market and would be suspended…

Continue Reading

MondayMay 06, 2024 3:07 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches New Research Program to Evaluate DehydraTECH-GLP-1 Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, related to its mode of action and performance. According to the announcement, the research will be conducted in partnership with the National Research Council of Canada (“NRC”). “We are excited about our partnership with the NRC for the mode of action molecular characterization of DehydraTECH-GLP-1 drugs. This work program could potentially provide data to assist Lexaria’s efforts in partnering with the pharmaceutical industry for the most rapid…

Continue Reading

MondayMay 06, 2024 3:03 pm

NetworkNewsBreaks – Aileron Therapeutics Inc. (NASDAQ: ALRN) Closes Underwritten Registered Direct Offering

Aileron Therapeutics (NASDAQ: ALRN) is a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications. The company has announced the closing of its underwritten registered direct offering priced at-the-market under Nasdaq rules of 4,273,505 shares of its common stock and accompanying warrants to purchase an aggregate of 4,273,505 shares of common stock. Aileron secured aggregate gross proceeds of approximately $20 million, before deducting underwriting discounts and commissions and other offering expenses and excluding any proceeds that may be received from exercise of the warrants. Titan Partners Group, a…

Continue Reading

MondayMay 06, 2024 2:29 pm

NetworkNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Inks Agreement with NAFG, Board Adopts Limited Duration Stockholder Rights Plan

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has added a commercial dealer to its growing list of dealerships. The company announced that National Auto Fleet Group (“NAFG”) will offer Mullen’s full line of all-electric commercial vehicles, specifically in Northern and Southern California. NAFG is a Sourcewell contract awardee and provides fleet vehicle purchasing to state, local government and educational institutions; Sourcewell is a government agency that has fulfilled bidding requirements and holds hundreds of competitively solicited contracts ready for use. “Everything you see, smell or touch was moved by truck at one time or another,” said National Fleet…

Continue Reading

MondayMay 06, 2024 1:55 pm

NetworkNewsBreaks – Turbo Energy S.A. (NASDAQ: TURB) Announces Filing of Patent Application in Spain for Sunbox Commercial, Industrial Product

Turbo Energy S.A. (NASDAQ: TURB), a leader in the field of photovoltaic energy storage, has filed a patent application with the Spanish Patent and Trademark Office (“OEPM”); the patent covers Turbo’s Sunbox Commercial & Industrial (“Sunbox C&I”) product, which is already available on the market. The Sunbox product is designed to provide the most efficient, adaptable solution for both isolated and grid-connected projects. The Sunbox C&I software allows Turbo Energy’s proprietary technology to be combined with any previously operational facility, allowing for standardization of the system as well as being more cost effective. The Sunbox system is the most efficient…

Continue Reading

MondayMay 06, 2024 11:21 am

NetworkNewsBreaks – Upstream Delves into Key Dual Listing Considerations for Issues

Upstream, a MERJ Exchange market and trading app, recently published a blog article written by Fernanda De La Torre and Vanessa Malone. The piece reiterates strategic benefits that dual listing offers to companies aiming to appeal to international investors and shifts focus to the essential factors that issuers should consider when contemplating dual listing and how Upstream addresses these challenges. “Dual listing continues to be used as a growth strategy for issuers as they go global. It’s important to think about regulatory compliance, costs and management resources inherent in this process,” the blog reads. “With our streamlined approach and comprehensive…

Continue Reading

MondayMay 06, 2024 8:30 am

NetworkNewsBreaks – NanoViricides Inc. (NYSE American: NNVC) Reports that NV-387 Shows Strong Activity Against Influenza A

NanoViricides (NYSE American: NNVC), a global leader in broad-spectrum antiviral nanomedicines, is reporting that the ultra-broad antiviral activity spectrum of NV-387 includes influenza A viruses, possibly including bird flu H5N1 virus as well. According to the announcement, the company performed a lethal animal model of lung infection by influenza A/H3N2 virus that indicated NV-387 showed superior antiviral effects compared to three approved anti-influenza drugs: Oseltamivir (Tamiflu[R], Roche), Peramivir (Rapivab[R], Biocryst), and Baloxivir (Xofluza[R], Shionogi, Roche). “We are pleasantly surprised by this extremely broad and strong antiviral activity of NV-387,” said NanoViricides president and executive chair Anil R. Diwan, PhD, in…

Continue Reading

FridayMay 03, 2024 9:54 am

NetworkNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Schedules Release of Q1 2024 Financial Results, Earnings Call

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, is planning to release its financial results for the first quarter of 2024, or the period ended March 31,  2024. The company announced that it will release the Q1 financial report on May 9, 2024, after the market closes. In addition, the company will host a conference call/live webcast that same day to discuss the financial report; the call will begin at 5 p.m. Those interested in accessing the call can dial (844) 308-3351 or (412) 317-5407. An archived version of the call will be available on…

Continue Reading